No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
Matricelf Ltd, a biotechnology company, develops a platform for autologous tissue engineering for various medical conditions. The company’s regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson’s disease, and myocardial infarction, as well as for 3D bioprinting. The company has a strategic collaboration with Sheba Medical Center for the development and clinical advancement of its neural tissue implant product for the treatment of spinal cord injury. The company has a strategic collaboration with CiRA Foundation for the development of regenerative manufacturing technologies and the evaluation of iPSC-based neural tissue engineering for therapeutic applications. The company was incorporated in 2019 and is based in Ness Ziona, Israel.
matricelf.comNo one on the platform currently holds MTLF.TA.
No tracked institution reports a position in MTLF.TA as of their last filing.
No one on the platform has traded MTLF.TA yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| MTLF.TAMatricelf Ltd. | $265.60 | +1.26% | $81M | — |
| BLRX.TABioLineRx Ltd. | $1.30 | +0.00% | $34M | — |
| CANF.TACan-Fite BioPharma Ltd. | $348.90 | -0.23% | $15M | — |
| CBI.TAClal Biotechnology Industries Ltd. | $24.70 | +0.82% | $39M | — |
| EMITF-M.TAElbit Imaging Ltd. | $613.49 | -2.39% | $81M | — |
| ENLV.TAEnlivex Therapeutics Ltd. | $269.70 | +0.00% | $66M | — |
| EVGN.TAEvogene Ltd. | $158.10 | +9.03% | $14M | — |
Source: Financial Modeling Prep · peers by sector/industry